628
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Skeletal muscle mitochondrial dysfunction in Type 2 diabetes

, &
Pages 475-477 | Published online: 10 Jan 2014

References

  • Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes and obesity-related health risk factors. JAMA1, 76–79 (2003).
  • Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol. Rev.75, 473–486 (1995).
  • Befroy DE, Petersen KF, Dufour S et al. Impaired mitochondrial oxidation in muscle of insulin resistant offspring of Type 2 diabetic patients. Diabetes56, 1376–1381 (2007).
  • Hancock CR, Hancock CR, Han DH et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl Acad. Sci. USA105, 7815–7820 (2008).
  • Bonen A, Parolin ML, Steinberg GR et al. Triaglycerol accumulation in human obesity and Type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD 36. FASEB J.18, 1144–1146 (2004).
  • Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab.7, 45–56 (2008).
  • Hirabara SM, Curi R, Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J. Cell. Physiol.222, 187–194 (2010).
  • Kelly DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in Type 2 diabetes. Diabetes51, 2944–2950 (2002).
  • Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, Kelly DE. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am. J. Physiol. Endocrinol. Metab.288, E818–E825 (2005).
  • Ritov VB, Menshikova EV, Azuma K et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in Type 2 diabetes mellitus and obesity. Am. J. Physiol. Endocrinol. Metab.298, E49–E58 (2010).
  • Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin resistant offspring of patients with Type 2 diabetes. N. Engl. J. Med.350, 664–671 (2004).
  • Boushel R, Gnaiger E, Schjerling P, Skovbro M, Krounsoe R, Dela F. Patients with Type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia50, 790–796 (2007).
  • Ortenblad N, Morgensen M, Petersen I et al. Reduced insulin mediated citrate synthase activity in cultured skeletal muscle cells from patients with Type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim. Biophys. Acta1741, 2006–2214 (2005).
  • Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of Type 2 diabetic parents. PLoS Med.2, E233 (2005).
  • Morino K, Petersen KF, Dufour S et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin resistant offspring of Type 2 diabetic patients. J. Clin. Invest.15(21), 3587–3593 (2005).
  • Szendroedi J, Schmid AI, Chmelik M et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in Type 2 diabetes. PLoS Med.4, E154 (2007).
  • Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes. Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA100, 8466–8471 (2003).
  • Toledo FG, Watkins S, Kelly DE et al. Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J. Clin. Endocrinol. Metab.1, 3224–3227 (2006).
  • Mogensen M, Sahlin K, Fernström M et al. Mitochondrial respiration is decreased in skeletal muscle of patients with Type 2 diabetes. Diabetes56, 1592–1599 (2007).
  • Phielix E, Schrauwen-Hinderling VB, Mensink M et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscles of male Type 2 diabetic patients. Diabetes57, 2943–2949 (2008).
  • Mensink M, Hesselink MK, Russel AP et al. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 a and PPAR b/d gene expression upon rosiglitazone treatment in obese patients with Type 2 diabetes mellitus. Int. J. Obes.31, 1302–1310 (2007).
  • Hwang H, Bowen BP, Lefort N et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and Type 2 diabetes. Diabetes59, 33–42 (2010).
  • Bach D, Naon D, Pich S et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 obesity, weight loss, and the regulatory role of tumor necrosis factor a and interleukin-6. Diabetes54, 2685–2693 (2005).
  • Toledo FG, Menshikova EV, Azuma K et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increase in insulin action and decreases in intermyocellular lipid content. Diabetes57, 987–994 (2008).
  • Meex RCR, Schrauwen-Hinderling VB, Moonen-Kornips E et al. Restoration of muscle mitochondrial function and metabolic flexibility in Type 2 diabetes by exercise training is paralleled by increased intramyocellular fat storage and improved insulin sensitivity. Diabetes59, 572–679 (2010).
  • Rabol R, Larsen S, Hojberg PM et al. Regionalanatomic differences in skeletal muscle mitochondrial respiration in Type 2 diabetes and obesity. J. Clin. Endocrinol. Metab.95, 857–863 (2010)
  • Fagot-Campagna A, Pettit DJ, Engelgau MM et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr.136, 664–672 (2000).
  • McQuaid S, O’Gorman DJ, Yousif O et al. Early onset insulin-resistant diabetes in obese Caucasians has features of typical Type 2 diabetes, but 3 decades earlier. Diabetes Care28, 1216–1218 (2005).
  • Hernandez-Alvarez MI, Thabit H, Burns N et al. Subjects with early onset Type 2 diabetes show defective activation of the skeletal muscle PGC-1a/mitofusin 2 regulatory pathway in response to physical activity. Diabetes Care33, 645–651 (2010).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.